Hims and Hers Health HIMS - 옵션 체인 | ADVFN

다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NYSE
Hims and Hers Health Inc (HIMS)
Hims and Hers Health Inc (HIMS) 옵션

Hims and Hers Health Inc (HIMS)

31.225

-0.695

( -2.18% )

업데이트: 22:55:26

HIMS 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
26.00	5.10	5.65	11.37	5.375	0.00	0.00 %	0	57	-
26.50	4.55	5.20	0.00	4.875	0.00	0.00 %	0	0	-
27.00	4.00	4.70	7.61	4.35	0.00	0.00 %	0	14	-
27.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
28.00	3.15	3.35	3.30	3.25	-0.70	-17.50 %	1	29	22:48:05
28.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
29.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
29.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
30.00	1.28	1.46	2.01	1.37	0.00	0.00 %	0	328	-
30.50	0.86	1.08	1.05	0.97	-0.84	-44.44 %	8	181	22:47:13
31.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
31.50	0.26	0.54	0.40	0.40	-0.55	-57.89 %	14	89	22:53:43
32.00	0.18	0.21	0.20	0.195	-0.50	-71.43 %	202	768	22:55:06
32.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
33.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
33.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
34.00	0.02	0.03	0.02	0.025	-0.11	-84.62 %	211	968	22:53:54
34.50	0.02	0.02	0.02	0.02	-0.08	-80.00 %	53	904	22:55:21
35.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
35.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

개인 투자자를 위한 전문가급 도구.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
26.00	0.02	0.03	0.02	0.025	0.00	0.00 %	0	194	-
26.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
27.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
27.50	0.01	0.06	0.04	0.035	-0.02	-33.33 %	2	74	22:35:16
28.00	0.02	0.05	0.04	0.035	0.01	33.33 %	5	547	22:42:19
28.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
29.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
29.50	0.10	0.11	0.10	0.105	0.00	0.00 %	0	302	-
30.00	0.11	0.16	0.11	0.135	-0.02	-15.38 %	28	1,384	22:50:36
30.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
31.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
31.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
32.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
32.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
33.00	1.74	2.04	1.55	1.89	0.17	12.32 %	35	2,657	22:51:05
33.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
34.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
34.50	3.20	3.35	3.22	3.275	0.56	21.05 %	16	221	22:54:35
35.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
35.50	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

가장 활성
% 상승자
% 패자

기호	가격	볼륨
PRTGPortage Biotech Inc	US$ 10.74 (128.03%)	18.14M
LXRXLexicon Pharmaceuticals Inc	US$ 0.639 (83.83%)	154.27M
DBVTDBV Technologies SA	US$ 6.1123 (56.32%)	10.75M
SNSESensei Biotherapeutics Inc	US$ 0.62875 (45.95%)	19.37M
TWGTop Wealth Group Holding Ltd	US$ 0.2381 (30.25%)	95.98M
MISTMilestone Pharmaceuticals Inc	US$ 0.8567 (-61.92%)	16.95M
XTIAXTI Aerospace Inc	US$ 1.2987 (-47.21%)	702.1k
DRCTDirect Digital Holdings Inc	US$ 0.7329 (-44.89%)	763.74k
ECXECARX Holdings Inc	US$ 1.5389 (-31.91%)	9.33M
SAIHSAIHEAT Ltd	US$ 3.93 (-31.29%)	18.04k
LXRXLexicon Pharmaceuticals Inc	US$ 0.639 (83.83%)	154.27M
TWGTop Wealth Group Holding Ltd	US$ 0.2381 (30.25%)	95.98M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10.605 (-0.14%)	47.16M
NVDANVIDIA Corporation	US$ 111.65 (0.20%)	36.1M
DMNDamon Inc	US$ 0.0355 (-20.40%)	29.5M

a surfer

a surfer 4 주 전

Beautiful comeback after the annihilation. I expect this to settle into the 50's.
The future growth still looks promising.

a surfer

a surfer 1 월 전

Hims & Hers Health Inc (HIMS.NaE) shares are tumbling Tuesday on the heels of the company’s fourth-quarter financial results. Here’s what you need to know.

What Happened: Hims & Hers Health (HIMS.NaE) reported fourth-quarter revenue of $481.14 million, beating estimates of $470.31 million, according to Benzinga Pro. The company reported fourth-quarter earnings of 11 cents per share, in line with analyst estimates.

Total revenue was up 69% on a year-over-year basis. Subscribers grew to 2.2 million in the quarter, up 45% year-over-year. Gross margin was 77% in the fourth quarter, which came up short of analyst estimates of 78.4%, according to CNBC.

Hims & Hers Health (HIMS.NaE) shares have been on a tear since the company said it would begin selling compounded versions of GLP-1 injections last year. The stock fell more than 20% on Friday after the U.S. Food and Drug Administration removed semaglutide injections from the shortage list. Hims & Hers said this week that its GLP-1 offering brought in over $225 million in revenue in 2024.

“2024 was a fantastic year at Hims and Hers as we continue to build a platform that leverages personalization and technology unlike any traditional healthcare system,” said Andrew Dudum, co-founder and CEO of Hims & Hers Health (HIMS.NaE).

“In the coming years, we expect to further transform how individuals can improve their health with more comprehensive treatments, technologies that normalize unlimited follow up support, and tools that can eventually be exported beyond Hims and Hers, enabling even more Americans to access this care.”

See Also: DocuSign Boasts 13% Revenue Growth In Q4, Raises Full-Year Guidance Due To AI Momentum

Hims & Hers Health (HIMS.NaE) guided for first-quarter revenue of $520 million to $540 million. The company expects full-year 2025 revenue to be in the range of $2.3 billion to $2.4 billion versus estimates of $2.087 billion, according to Benzinga Pro.

Following the company’s quarterly results, Citigroup analyst Daniel Grosslight maintained Hims & Hers with a Sell and raised the price target from $25 to $27. Needham analyst Ryan MacDonald maintained a Buy rating and raised the price target from $31 to $61.

HIMS Price Action: Hims & Hers Health (HIMS.NaE) shares were down 19.6% at $41.15 at the time of publication Tuesday, according to Benzinga Pro.

Photo: Shutterstock.

a surfer

a surfer 1 월 전

Just slammed 20k in 36's myself. Love it.

fung_derf

fung_derf 1 월 전

This waaayyyyy overreacted to their reporting a weight loss drug. I just can't tell if the buyback is $35 or $29?

runemup

runemup 1 월 전

Buying the shares I sold at 57 back today 😁. I love these over reactions to good numbers and good guidance. Fundamentals have not changed here. Solid growth ahead for hims

fung_derf

fung_derf 1 월 전

Is this Jeopardy? OK, I'll play.....
What is the newest pump and dump?

Monksdream

Monksdream 1 월 전

HIMS, 10Q due MONDAY 2/24

ChrisMc75

ChrisMc75 1 월 전

a surfer

a surfer 1 월 전

Mojocash

Mojocash 1 월 전

runemup

runemup 1 월 전

$72 ouch for anyone short!

tw0122

tw0122 1 월 전

Weight loss made affordable nice play

Monksdream

Monksdream 1 월 전

HIMS, new 52 week high

a surfer

a surfer 1 월 전

Truly incredible moves!

TechandBio

TechandBio 1 월 전

Shorts are getting wrecked! :)

$HIMS

TechandBio

TechandBio 1 월 전

HIMS holding a core at 13.50
Short % of Float (1/31/2025) 30.35%
Short % of Shares Outstanding (1/31/2025) 26.64%

$HIMS

a surfer

a surfer 2 월 전

Monksdream

Monksdream 2 월 전

HIMS, new 52=high

fung_derf

fung_derf 3 월 전

Sharectile dysfunction? It can only stay up for so long.

infamous

infamous 3 월 전

hows is this 16% down premarket already today? what gives?

Monksdream

Monksdream 4 월 전

HIMS, just under the 52 week high

a surfer

a surfer 4 월 전

My luck was not paying attention to it too diligently...lol

fung_derf

fung_derf 4 월 전

I sold too soon, but to be fair, it already looks pricey.

a surfer

a surfer 4 월 전

Been one hell of a run. I took a few off. Been holding most from $6

fung_derf

fung_derf 4 월 전

Well, it sure hit $32 quickly enough. Now do we see the big breakout, or pullback? I should have taken my own advice here...

If you had played this stock right, it would have made for a nice roller coaster. I rode it once from $13 to $19. It looks like the next stop may be around $32.
Of course it is also the epitome of a high risk stock.

Monksdream

Monksdream 4 월 전

HIMS, new 52 week high

PonkenPlonken

PonkenPlonken 4 월 전

I wish for a world in which they are able to punish these laughable selloffs on some lukewarm excuse...
As seen in ADMA, HOOD, TSLA and here. Technically its fine... Practically what they are doing is an orchestrated maneuver to scam gullible investors living on buy/sell panic diet

Monksdream

Monksdream 4 월 전

HIMS new 52 week high

Monksdream

Monksdream 5 월 전

Dennisb68

Dennisb68 5 월 전

IKT is having a fantastic run!

fung_derf

fung_derf 5 월 전

If you had played this stock right, it would have made for a nice roller coaster. I rode it once from $13 to $19. It looks like the next stop may be around $32.
Of course it is also the epitome of a high risk stock.

BIOCHEMUP

BIOCHEMUP 5 월 전

Monksdream

Monksdream 6 월 전

Good morning! In the latest GLP-1 news, the FDA reported last week that Eli Lilly’s weight loss and diabetes drug Mounjaro is no longer facing a shortage. This means pharmacy companies that have been compounding the medication, a process that uses the same ingredients and is only allowed in times of shortages, can no longer do so. Novo Nordisk’s Ozempic and Wegovy are not affected by this, and will likely continue to be distributed by compounding pharmacies, including Hims and Hers.

Monksdream

Monksdream 6 월 전

Monksdream

Monksdream 8 월 전

HIMS 10Q due AUGUST5

Monksdream

Monksdream 9 월 전

r clarke

r clarke 9 월 전

HIMS selling compounded GLP-1 despite the FDA warnings.
Compounding is allowed during shortages, but there may be issues with supplier?
Compounded drug is not FDA tested or approved.
Possible short candidate if it heads higher?

Monksdream

Monksdream 9 월 전

HIMS new 52 week high

Monksdream

Monksdream 9 월 전

HIMS new 52 week high

Monksdream

Monksdream 10 월 전

HIMS new 52 week high

Dennisb68

Dennisb68 10 월 전

God Bless Israel!

Dennisb68

Dennisb68 10 월 전

God Bless Israel.

Dennisb68

Dennisb68 10 월 전

Just sold my shares after learning about the dirt bag CEO. Hope the company tanks.

trendzone

trendzone 10 월 전

Share holders woke up to limp one, will have to take some viagra to get a pump.

bikaver

bikaver 10 월 전

HIMS..... From 16.21 to 20.45 in five days is good enough for me. Adios and GLTA

Monksdream

Monksdream 10 월 전

HIMS new 52 week high

bikaver

bikaver 10 월 전

trendzone

trendzone 10 월 전

It's selling off on being down graded, you would have to be a total fool selling $15 puts at $0.05.

Monksdream

Monksdream 10 월 전

HIMS new 52 week high
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc

Greedy G

Greedy G 11 월 전

~RIPPn on nice beat

Hims and Hers Health

XMNUE1D CHF iNAV

US Physical Therapy

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관